United States Air Force School of Aerospace Medicine, Epidemiology Consult Service Division, 2510 Fifth Street, Building 840, Wright-Patterson AFB, OH, 45433, USA.
Department of Nutritional Sciences, Texas Tech University, Box 41270, Lubbock, TX, 79409-1240, USA.
Curr Obes Rep. 2017 Mar;6(1):28-37. doi: 10.1007/s13679-017-0251-1.
Obesity is a multifactorial disease that is now endemic throughout most of the world. Although addressing proximate causes of obesity (excess energy intake and reduced energy expenditure) have been longstanding global health priorities, the problem has continued to worsen at the global level.
Numerous microbial agents cause obesity in various experimental models-a phenomena known as infectobesity. Several of the same agents alter metabolic function in human cells and are associated with human obesity or metabolic dysfunction in humans. We address the evidence for a role in the genesis of obesity for viral agents in five broad categories: adenoviridae, herpesviridae, phages, transmissible spongiform encephalopathies (slow virus), and other encephalitides and hepatitides. Despite the importance of this topic area, there are many persistent knowledge gaps that need to be resolved. We discuss factors motivating further research and recommend that future infectobesity investigation should be more comprehensive, leveraged, interventional, and patient-centered.
肥胖是一种多因素疾病,目前在世界上大多数地区都普遍存在。尽管解决肥胖的近因(能量摄入过多和能量消耗减少)一直是全球卫生的长期重点,但这一问题在全球范围内仍持续恶化。
许多微生物制剂在各种实验模型中导致肥胖——这一现象被称为感染性肥胖。其中一些相同的制剂改变了人类细胞的代谢功能,并与人类肥胖或代谢功能障碍有关。我们针对腺病毒科、疱疹病毒科、噬菌体、传染性海绵状脑病(慢病毒)和其他脑炎和肝炎等五类病毒制剂在肥胖产生中的作用的证据进行了探讨。尽管这一主题领域非常重要,但仍存在许多需要解决的知识空白。我们讨论了推动进一步研究的因素,并建议未来的感染性肥胖研究应该更加全面、有针对性、干预性和以患者为中心。